missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human OSMR beta Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Brand: R&D Systems™ 4389-OR-050
This item is not returnable.
View return policy
Description
The Recombinant Human OSM R beta Protein is derived from NS0. The Recombinant Human OSM R beta Protein has been validated for the following applications: Binding Activity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 81 kDa | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 85%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 9180 | |
| OSMR beta | |
| Mouse myeloma cell line,NS0-derived human OSM R beta protein Glu28-Ser739 | |
| IL-31 receptor subunit beta, IL-31R subunit beta, IL-31RB, IL-31R-beta, Interleukin-31 receptor subunit beta, MGC150627, MGC75127, oncostatin M receptor, oncostatin-M specific receptor beta subunit, oncostatin-M-specific receptor subunit beta, OSM R beta, OSMR, OSMRB, OSMRBMGC150626, PLCA1 | |
| Recombinant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction